Abstract
SP-0517 Countability rather than number of metastases to select patients for local ablative therapies (LAT) in oligometastatic disease and novel endpoints for trials and registries.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
